{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:42:45Z","timestamp":1792665765175,"version":"4.5.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>This review outlines the advancements that have been made in computational analysis for clinical flow cytometry data in hematological malignancies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>In recent years, computational analysis methods have been applied to clinical flow cytometry data of hematological malignancies with promising results. Most studies combined dimension reduction (principle component analysis) or clustering methods (FlowSOM, generalized mixture models) with machine learning classifiers (support vector machines, random forest). For diagnosis and classification of hematological malignancies, many studies have reported results concordant with manual expert analysis, including B-cell chronic lymphoid leukemia detection and acute leukemia classification. Other studies, e.g. concerning diagnosis of myelodysplastic syndromes and classification of lymphoma, have shown to be able to increase diagnostic accuracy. With respect to treatment response monitoring, studies have focused on, for example, computational minimal residual disease detection in multiple myeloma and posttreatment classification of healthy or diseased in acute myeloid leukemia. The results of these studies are encouraging, although accurate relapse prediction remains challenging. To facilitate clinical implementation, collaboration and (prospective) validation in multicenter setting are necessary.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Computational analysis methods for clinical flow cytometry data hold the potential to increase ease of use, objectivity and accuracy in the clinical work-up of hematological malignancies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cco.0000000000000607","type":"journal-article","created":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T19:21:27Z","timestamp":1577215287000},"page":"162-169","source":"Crossref","is-referenced-by-count":46,"title":["Computational analysis of flow cytometry data in hematological malignancies: future clinical practice?"],"prefix":"10.1097","volume":"32","author":[{"given":"Carolien","family":"Duetz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costa","family":"Bachas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresia M.","family":"Westers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan A.","family":"van de Loosdrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230901","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000490727","article-title":"Clinical implication of multi-parameter flow cytometry in myelodysplastic syndromes","volume":"86","author":"Duetz","year":"2019","journal-title":"Pathobiology"},{"key":"R2-20230901","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1182\/blood-2016-07-726307","article-title":"Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia","volume":"129","author":"Theunissen","year":"2017","journal-title":"Blood"},{"key":"R3-20230901","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1182\/blood-2017-09-801498","article-title":"Minimal\/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party","volume":"131","author":"Schuurhuis","year":"2018","journal-title":"Blood"},{"key":"R4-20230901","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1182\/blood-2007-11-120535","article-title":"Flow cytometric immunophenotyping for hematologic neoplasms","volume":"111","author":"Craig","year":"2008","journal-title":"Blood"},{"key":"R5-20230901","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nri.2016.56","article-title":"Computational flow cytometry: helping to make sense of high-dimensional immunology data","volume":"16","author":"Saeys","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"(Suppl 1)","key":"R6-20230901","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/ijlh.13016","article-title":"Flow cytometry data analysis: recent tools and algorithms","volume":"41","author":"Montante","year":"2019","journal-title":"Int J Lab Hematol"},{"key":"R7-20230901","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/eji.201545774","article-title":"The end of gating? An introduction to automated analysis of high dimensional cytometry data","volume":"46","author":"Mair","year":"2016","journal-title":"Eur J Immunol"},{"key":"R8-20230901","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nbt.2594","article-title":"viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia","volume":"31","author":"Amir","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"(Nov)","key":"R9-20230901","first-page":"2579","article-title":"Visualizing high-dimensional data using t-SNE","volume":"9","author":"van derMaaten","year":"2008","journal-title":"J Machine Learning Res"},{"key":"R10-20230901","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/978-3-642-04898-2_455","article-title":"Principal component analysis","author":"Jolliffe","year":"2011","journal-title":"International encyclopedia of statistical science"},{"key":"R11-20230901","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/cyto.a.22625","article-title":"FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data","volume":"87","author":"Van Gassen","year":"2015","journal-title":"Cytometry A"},{"key":"R12-20230901","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/cyto.a.23030","article-title":"Comparison of clustering methods for high-dimensional single-cell flow and mass cytometry data","volume":"89","author":"Weber","year":"2016","journal-title":"Cytometry A"},{"key":"R13-20230901","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/nbt.1991","article-title":"Extracting a cellular hierarchy from high-dimensional cytometry data with SPADE","volume":"29","author":"Qiu","year":"2011","journal-title":"Nat Biotechnol"},{"key":"R14-20230901","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.2017.18391","article-title":"Big data and machine learning in healthcare","volume":"319","author":"Beam","year":"2018","journal-title":"JAMA"},{"key":"R15-20230901","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/cyto.b.21588","article-title":"PhenoGraph and viSNE facilitate the identification of abnormal T-cell populations in routine clinical flow cytometric data","volume":"94","author":"DiGiuseppe","year":"2018","journal-title":"Cytometry B Clin Cytom"},{"issue":"(Suppl 7:S1)","key":"R16-20230901","article-title":"Automatic B cell lymphoma detection using flow cytometry data","volume":"14","author":"Shih","year":"2013","journal-title":"BMC Genomics"},{"key":"R17-20230901","doi-asserted-by":"crossref","first-page":"112662","DOI":"10.1016\/j.jim.2019.112662","article-title":"EuroFlow Lymphoid Screening Tube (LST) data base for automated identification of blood lymphocyte subsets","author":"Flores-Montero","year":"2019","journal-title":"J Immunol Methods"},{"key":"R18-20230901","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nmeth.2365","article-title":"Critical assessment of automated flow cytometry data analysis techniques","volume":"10","author":"Aghaeepour","year":"2013","journal-title":"Nat Methods"},{"key":"R19-20230901","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random Forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Machine Learning"},{"key":"R21-20230901","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3324\/haematol.2016.147843","article-title":"Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes","volume":"102","author":"Cremers","year":"2017","journal-title":"Haematologica"},{"key":"R22-20230901","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1038\/leu.2010.160","article-title":"Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping","volume":"24","author":"Costa","year":"2010","journal-title":"Leukemia"},{"key":"R23-20230901","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/leu.2017.313","article-title":"Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia","volume":"32","author":"Lhermitte","year":"2018","journal-title":"Leukemia"},{"key":"R24-20230901","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/leu.2012.120","article-title":"EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes","volume":"26","author":"van Dongen","year":"2012","journal-title":"Leukemia"},{"key":"R25-20230901","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1309\/AJCPMMLQ67YOMGEW","article-title":"Automated analysis of multidimensional flow cytometry data improves diagnostic accuracy between mantle cell lymphoma and small lymphocytic lymphoma","volume":"137","author":"Zare","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"R26-20230901","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3389\/fonc.2019.00726","article-title":"Minimal residual disease in acute lymphoblastic leukemia: technical and clinical advances","volume":"9","author":"Della Starza","year":"2019","journal-title":"Front Oncol"},{"key":"R27-20230901","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1038\/leu.2017.29","article-title":"Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma","volume":"31","author":"Flores-Montero","year":"2017","journal-title":"Leukemia"},{"key":"R28-20230901","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/1471-2105-7-282","article-title":"Automated in-silico detection of cell populations in flow cytometry readouts and its application to leukemia disease monitoring","volume":"7","author":"Toedling","year":"2006","journal-title":"BMC Bioinformatics"},{"key":"R29-20230901","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cyto.a.21148","article-title":"Detection and monitoring of normal and leukemic cell populations with hierarchical clustering of flow cytometry data","volume":"81A","author":"Fi\u0161er","year":"2012","journal-title":"Cytometry A"},{"key":"R30-20230901","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/cyto.a.23852","article-title":"Automated flow cytometric MRD assessment in childhood acute B- lymphoblastic leukemia using supervised machine learning","volume":"95","author":"Reiter","year":"2019","journal-title":"Cytometry A"},{"key":"R32-20230901","doi-asserted-by":"crossref","first-page":"71915","DOI":"10.18632\/oncotarget.12430","article-title":"Automated analysis of acute myeloid leukemia minimal residual disease using a support vector machine","volume":"7","author":"Ni","year":"2016","journal-title":"Oncotarget"},{"key":"R33-20230901","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ebiom.2018.10.042","article-title":"Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome","volume":"37","author":"Ko","year":"2018","journal-title":"EBioMedicine"},{"issue":"(Suppl 1)","key":"R34-20230901","first-page":"980","article-title":"An artificial intelligence approach for B lymphoblastic leukemia minimal residual disease detection and clinical prognosis prediction using flow cytometry data (Conference abstract ASH annual meeting 2017)","volume":"130","author":"Wang","year":"2017","journal-title":"Blood"},{"key":"R35-20230901","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1109\/TBME.2016.2590950","article-title":"Automated assessment of disease progression in acute myeloid leukemia by probabilistic analysis of flow cytometry data","volume":"64","author":"Rajwa","year":"2017","journal-title":"Trans Biomed Eng"},{"key":"R36-20230901","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/cyto.b.21252","article-title":"Detection of minimal residual disease in B lymphoblastic leukemia using viSNE","volume":"88","author":"DiGiuseppe","year":"2015","journal-title":"Cytometry B Clin Cytom"},{"key":"R37-20230901","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.cll.2017.07.011","article-title":"Automated analysis of clinical flow cytometry data: a chronic lymphocytic leukemia illustration","volume":"37","author":"Scheuermann","year":"2017","journal-title":"Clin Lab Med"},{"key":"R38-20230901","article-title":"Phenotypic landscape of granulocytes and monocytes by multiparametric flow cytometry: a prospective study of a 1-tube panel strategy for diagnosis and prognosis of patients with MDS","author":"Barreau","year":"2019","journal-title":"Cytometry B Clin Cytom"},{"key":"R39-20230901","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/leu.2017.313","article-title":"Automated database-guided expert-supervised orientation for immunophenotypic diagnosis and classification of acute leukemia","volume":"32","author":"Lhermitte","year":"2018","journal-title":"Leukemia"},{"key":"R40-20230901","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.3324\/haematol.2017.169029","article-title":"Phenotype in combination with genotype improves outcome prediction in acute myeloid leukemia: a report from Children's Oncology Group protocol AAML0531","volume":"102","author":"Voigt","year":"2017","journal-title":"Haematologica"},{"key":"R41-20230901","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/cyto.a.20638","article-title":"A probabilistic approach for the evaluation of minimal residual disease by multiparameter flow cytometry in leukemic B-cell chronic lymphoproliferative disorders","volume":"73A","author":"Pedreira","year":"2008","journal-title":"Cytometry A"},{"key":"R42-20230901","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s12185-015-1923-9","article-title":"Stepwise discriminant function analysis for rapid identification of acute promyelocytic leukemia from acute myeloid leukemia with multiparameter flow cytometry","volume":"103","author":"Chen","year":"2016","journal-title":"Int J Hematol"},{"key":"R43-20230901","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41408-018-0153-9","article-title":"Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC)","volume":"8","author":"Sanoja-Flores","year":"2018","journal-title":"Blood Cancer J"},{"key":"R44-20230901","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41591-018-0307-0","article-title":"The practical implementation of artificial intelligence technologies in medicine","volume":"25","author":"He","year":"2019","journal-title":"Nat Med"},{"key":"R45-20230901","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/s41591-019-0548-6","article-title":"Do no harm: a roadmap for responsible machine learning for healthcare","volume":"25","author":"Wiens","year":"2019","journal-title":"Nat Med"},{"key":"R46-20230901","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jamaoncol.2018.2706","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the Global Burden of Disease Study","volume":"4","author":"Fitzmaurice","year":"2018","journal-title":"JAMA Oncol"},{"key":"R47-20230901","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/his.12993","article-title":"Digital pathology in clinical use: where are we now and what is holding us back?","volume":"70","author":"Griffin","year":"2017","journal-title":"Histopathology"}],"container-title":["Current Opinion in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CCO.0000000000000607","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T07:12:27Z","timestamp":1693552347000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CCO.0000000000000607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/cco.0000000000000607","relation":{},"ISSN":["1040-8746","1531-703X"],"issn-type":[{"value":"1040-8746","type":"print"},{"value":"1531-703X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3]]}}}